Cambridge scientists develop first 'AI vaccine' against coronaviruses

📌 Summary:

• A University of Cambridge team has engineered a "fundamentally new" vaccine using Artificial Intelligence that could protect against all coronaviruses and help prevent future pandemics.
• It is the first time a vaccine's key component has been designed entirely by AI and then trialled on humans.
• Method: AI analysed recorded genetic codes and designed a "super-antigen" that trains the immune system to protect against a wide family of viruses and keep pace with mutations and animal-to-human spillover.
• Significance: a shift from reactive (one-strain-at-a-time) to proactive, broad-spectrum vaccine design — aiming to "get ahead of the curve" (Prof Jonathan Heeney).

🎯 UPSC Relevance: GS3 (Science & Technology — AI applications in biotechnology and health; pandemic preparedness; indigenisation and R&D parallels for India).

📝 Prelims Facts:

• Developed at the University of Cambridge; led by Prof Jonathan Heeney.
• The AI-designed component is a "super-antigen" targeting an entire virus family, not a single strain.
• First AI-designed vaccine component to reach human trials.

🔑 Key Term: Super-antigen — here, an AI-designed broad-spectrum antigen engineered to elicit immune protection across an entire family of related viruses rather than a single variant.